Viral infection drives tissue fibrosis in vitro

A. Malizia, D. Walls, J. Egan, P. Doran (Dublin, Ireland)

Source: Annual Congress 2007 - Novel mediators of cellular pathology
Session: Novel mediators of cellular pathology
Session type: Electronic Poster Discussion
Number: 3062
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Malizia, D. Walls, J. Egan, P. Doran (Dublin, Ireland). Viral infection drives tissue fibrosis in vitro. Eur Respir J 2007; 30: Suppl. 51, 3062

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Viral infection immunodetection reinforce the possible viral participation in the pulmonary fibrosis disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Inflammatory epithelial cytokines after in vitro respiratory syncytial viral infection are associated with reduced lung function
Source: ERJ Open Res, 7 (3) 00365-2021; 10.1183/23120541.00365-2021
Year: 2021

Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010

Accumulation of hyaluronan in the lumen of the airways enhances the pathology of respiratory viral infection
Source: Lung Science Conference 2015
Year: 2015

Ex vivo virus infection of HDM-sensitized lung tissue proves inadequate anti-viral immune response in small airways
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis
Source: Eur Respir J 2012; 39: 297-304
Year: 2012

Unravelling specific mechanisms of wound healing and pulmonary fibrosis in human ex vivo lung tissue slices
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

Effects of respiratory syncytial virus and adenovirus infection in cytokine expression and nuclear factor-κB activation human bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 192s
Year: 2006

Late Breaking Abstract - Efficient replication of respiratory syncytial virus induces a decrease of mucociliary clearance in human small airway 3D culture
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018

Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice
Source: Eur Respir J 2002; 20: 1228-1232
Year: 2002

Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract
Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016
Year: 2017

Azithromycin fails to restore apoptosis in cystic fibrosis airway epithelium post viral infection
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011

TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection
Source: Eur Respir J, 57 (6) 2003764; 10.1183/13993003.03764-2020
Year: 2021

Viral infection
Source: Eur Respir Monogr 2017; 77: 76-96
Year: 2017

Pathomechanisms mediating bacterial co-infection following respiratory viral disease
Source: Lung Science Conference 2015
Year: 2015

Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017